Skip to main content

What happens when you stop taking Gilenya?

Medically reviewed by Carmen Pope, BPharm. Last updated on June 26, 2024.

Official Answer by Drugs.com

Gilenya (fingolimod) is an immunosuppressant that may be used for the treatment of relapsing multiple sclerosis (MS) in adults, and children and adolescents aged 10 years and older.

In 2018, the FDA issued a warning stating that there is a possibility for some people that their MS may worsen significantly on stopping Gilenya.

This worsening is rare but could result in permanent disability. In the package insert for Gilenya it states that:

Before starting Gilenya, you need to be aware of the risk of an increase in disability should you need to stop it.

Reasons for stopping may include intolerable adverse drug reactions, planned or unplanned pregnancy, or because the medicine is not working.

In the 8 years since Gilenya was first approved in September 2010, 35 cases of severely increased disability accompanied by the presence of multiple new lesions on MRI have been reported that occurred 2 to 24 weeks after Gilenya was stopped.

Do not stop taking Gilenya without first talking to your prescriber. If you do stop Gilenya, you should monitor yourself for worsening symptoms and report them straight away to your doctor. These may include:

Because Gilenya suppresses the immune system, a person’s ability to fight infection will be diminished. If a person is also taking chemotherapy agents, immune-modulating therapies, or other immunosuppressants, these will have additive effects, further decreasing the ability of the immune system to respond to infection. Gilenya will also reduce the immune response to live vaccines.

Because Gilenya lasts in the blood for a long time, and lymphocyte counts take 1 to 2 months to return to baseline after stopping therapy, a person’s immune system will remain compromised for up to two months after stopping Gilenya treatment.

Related questions

References
  • FDA warns about severe worsening of multiple sclerosis after stopping the medicine Gilenya (fingolimod) FDA Safety Announcement 20 Nov 2018 https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-severe-worsening-multiple-sclerosis-after-stopping-medicine-gilenya-fingolimod#:~:text=Gilenya%20treatment%20may%20have%20to,lead%20to%20worsening%20MS%20symptoms
  • Gilenya (fingolimod) [Package Inserts]. Novartis Pharmaceuticals Corporation https://www.drugs.com/pro/gilenya.html

Read next

Can Gilenya cause headaches?

Yes, headaches are a common side effect with Gilenya and have been reported to occur in 10% or more of people in clinical studies. But if you have a sudden severe headache, or a headache with fever, neck stiffness, sensitivity to light, nausea, or confusion, call your doctor right away. Continue reading

Gilenya and the covid-19 vaccine, what should I know?

According to the National MS Society, COVID-19 vaccines are safe for people with MS taking Gilenya. If you are about to start Gilenya, then the National MS Society recommend that you should consider getting fully vaccinated with a COVID-19 vaccine at least 2 weeks prior to starting Gilenya. If you are already taking Gilenya, continue taking it as your doctor has prescribed and get a COVID-19 vaccine as soon as possible. Continue reading

See also:

Related medical questions

Drug information

Related support groups